Subscribe
Gwendolyn Tawresey, Brittany Reeves, Emma Mann, and Gillian Schutt
3 October 2025NewsAmericasEmma Mann, Gwendolyn Tawresey, Brittany Reeves, and Gillian Schutt

ITC probes on the rise, but gender parity lags behind

A spike in agency investigations and more female lead counsel still leave a notable gender gap at the venue, find Troutman Pepper Locke’s Emma Mann, Gwendolyn Tawresey, Brittany Reeves, and Gillian Schutt.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
'Scrap the billable hour': LSIPR joins INTA panel on gender diversity
22 May 2025   A lively session explored findings from a report co-authored by LSIPR sister title WIPR, urging the IP sector to call time on outdated metrics that delay or derail women’s professional progress.
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025   As the US legal sector comes under political pressure for its inclusion efforts, LSIPR's sister magazine reveals its Top 100 for 2025, highlighting the individuals fighting to keep progress at the heart of IP.
Americas
‘Lift as you climb’: Abbott, BMS, Hitachi, LEGO Group counsels explore ‘empowerment’
6 March 2025   Senior legal voices from the world’s biggest companies share perspective on International Women’s Day theme | Action is key as gender parity remains a distant goal–forecasted to take at least 134 years.


Editor's picks

A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
Americas
A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
23 October 2025

Editor's picks

Americas
A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
23 October 2025
Americas
Top pharma, biotech, and medtech experts gather at LSPN Fall
21 October 2025
Big Pharma
Moderna TM counsel: Commoditising work using AI is a ‘moral obligation’
16 October 2025
Americas
‘Death knell’ for investment: Universities warn against Lutnick’s royalty sharing proposal
13 October 2025
Americas
IP agencies vital to pharma and biotech grind to a halt
2 October 2025
Americas
Global vaccine patents rise, as data reveals shift in Big Pharma strategy
1 October 2025

More features

Is AI emerging as the ‘fourth party’ solving billion-dollar disputes?
Why AI is changing the patent rules faster than anyone can keep up
The hidden code in life sciences deals
LSPN panel unpacks critical IP risks in deal-making
A second bite at the cherry: Adjudicating redesigns after an ITC exclusion order
Less is more: patent lawyers flip the script after Amgen
‘Doing more with less’: In-house counsel on budgets and strategy
End of the ‘Death Squad’? Squires puts PTAB on trial